发明名称 Methods and DNA constructs for high yield production of polypeptides
摘要 The invention provides an inclusion body fusion partner to increase peptide and polypeptide production in a cell.
申请公布号 US9322025(B2) 申请公布日期 2016.04.26
申请号 US200912358966 申请日期 2009.01.23
申请人 Medtronic, Inc. 发明人 Williams James A.;Luan Peng;Xia Yuannan;Harley Scott
分类号 C07H21/04;C12N5/10;C07K19/00;C12N15/63;C07K14/60;C07K14/605;C07K14/635 主分类号 C07H21/04
代理机构 Mueting, Raasch & Gebhardt, P.A. 代理人 Mueting, Raasch & Gebhardt, P.A.
主权项 1. An expression cassette comprising a nucleotide sequence with the operably linked nucleic acid sequences: 5′ Pr-(TIS)D(IBFP1)E-(CL1)G-ORF-[CL2-ORF]L-(CL3)M-(IBFP2)Q-(SSC)R-(CL4)T-(Ft)W-(Tr)X-3′wherein the Pr is a promoter sequence, the TIS encodes a translation initiation sequence, the IBFP1 encodes a first inclusion body fusion partner comprising an amino acid sequence of any of SEQ ID NOS: 7-14 or a variant thereof, wherein the variant has 75% or greater sequence homology to at least one of SEQ ID NOS: 7-14 and wherein the variant includes a hydrophobic core consisting of residues 22-29 of SEQ ID NO:130, the CL1 encodes a first cleavable peptide linker, the ORFs encode a preselected polypeptide, the CL2 encodes a second cleavable peptide linker, the CL3 encodes a third cleavable peptide linker, the IBFP2 encodes a second inclusion body fusion partner comprising an amino acid sequence of any of SEQ ID NOS: 7-14 or a variant thereof, wherein the variant has 75% or greater sequence homology to at least one of SEQ ID NOS: 7-14 and wherein the variant includes the hydrophobic core consisting of residues 22-29 of SEQ ID NO:130, the SSC is a suppressible stop codon, the CL4 encodes a fourth cleavable peptide linker, the Ft encodes a fusion tag, and the Tr is a transcription terminator sequence, wherein each of D or X is independently 0 or an integer of 1 to 4, wherein R is 0 or an integer of 1 to 2, wherein each of E, G, L, M, Q, T or W is independently 0 or an integer of 1 to 20, wherein either one or both of a IBFP1 or a IBFP2 is present, and wherein expression of the nucleic acid sequence produces a tandem polypeptide that forms an inclusion body when expressed in a cell, wherein at least one of a CL1, a CL2, a CL3 or a CL4 is present.
地址 Minneapolis MN US